(Q41428763)

30 September 2017

1 reference

title

Genetics of drug resistance in tuberculosis (English)

1 reference

30 September 2017

1 reference

Telenti A

1

1 reference

30 September 2017

publication date

1 March 1997

1 reference

Clinics in Chest Medicine

30 September 2017

published in

1 reference

30 September 2017

volume

18

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

55-64

1 reference

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Resistance to quinolones in mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Mycobacterium tuberculosis: drug-resistance mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Rifamycin resistance in mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Streptomycin resistance in mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Permeability barrier to hydrophilic solutes in Mycobacterium chelonei

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Distribution and characterization of beta-lactamases of mycobacteria and related organisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Glycosyltransferases as targets for inhibition of cell wall synthesis in M. tuberculosis and M. avium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Biogenesis of the mycobacterial cell wall and the site of action of ethambutol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Drug resistance in mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

The genetics of multiple drug resistance in Mycobacterium tuberculosis and the Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Prevention of drug access to bacterial targets: permeability barriers and active efflux

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

The structure and function of the isoniazid target in M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

The new diagnostic mycobacteriology laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Emergence of fluoroquinolone-resistant tuberculosis in New York City.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Characterization of rifampin-resistance in pathogenic mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970355-5

7 January 2021

10.1016/S0272-5231(05)70355-5

Identifiers

DOI

1 reference

30 September 2017

1 reference